Exact Sciences
EXAS
#1384
Rank
โ‚น1.097 T
Marketcap
โ‚น5,942
Share price
2.34%
Change (1 day)
-5.26%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น292.02 B

According to Exact Sciences's latest financial reports the company's total liabilities are โ‚น292.02 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น276.88 B5.1%
2022-12-31โ‚น263.45 B7.22%
2021-12-31โ‚น245.72 B25.13%
2020-12-31โ‚น196.36 B126.55%
2019-12-31โ‚น86.67 B47.8%
2018-12-31โ‚น58.64 B1075.38%
2017-12-31โ‚น4.98 B75.88%
2016-12-31โ‚น2.83 B14.85%
2015-12-31โ‚น2.47 B63.72%
2014-12-31โ‚น1.50 B115.83%
2013-12-31โ‚น0.69 B-5.61%
2012-12-31โ‚น0.74 B4.02%
2011-12-31โ‚น0.71 B-5.25%
2010-12-31โ‚น0.75 B-18.01%
2009-12-31โ‚น0.91 B121.3%
2008-12-31โ‚น0.41 B26.44%
2007-12-31โ‚น0.32 B-17%
2006-12-31โ‚น0.39 B-33.69%
2005-12-31โ‚น0.59 B-16.54%
2004-12-31โ‚น0.71 B-30.39%
2003-12-31โ‚น1.02 B81.97%
2002-12-31โ‚น0.56 B182.23%
2001-12-31โ‚น0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น28.90 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.54 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.82 B-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.104 T 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France